Elena Garralda - Publications, H-index & Citations

Back

Elena Garralda

Vall d'Hebron University Hospital

46H-index

727Paper Count

1.0WCitation Count

Published Papers 186

Publication Date

Vobramitamab duocarmazine, an anti–B7-H3 antibody–drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion

Cancer

IF5.1

2026-08-11

OAAI

Eugene Shenderov MD, PhD; Manish R. Sharma MD; Elena Garralda MD; John Powderly MD; Iwona Ługowska MD; Alexander Spira MD, PhD; Marc Cucurull Salamero MD

Save

Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma

European Journal of Cancer

IF7.1

2026-06-24

PREAI

Elena Garralda; Patrick Schöffski; Arjun Oberoi; Martin Schuler; Heike Richly; Paolo A. Ascierto; Chia-Chi Lin; Rosa Álvarez; Sandip Pravin Patel; Yan Xing; Vivek Subbiah; Nancy Lewis; Shonika Patel; Lydia Wang-L-akshman; Jong Bong Lee; Nadia B. Hassounah; Lang Ho Lee; Mike Roy; Souvik Banerjee; Aimee Reynolds

Save

Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity

Clinical and Translational Science

IF2.8

2026-05-22

OAAI

Marije B. Overdijk; Kristin Strumane; Ruth Plummer; Patricia LoRusso; Jordi Rodon Ahnert; Udai Banerji; Elena Garralda; Emiliano Calvo; Han Si; Naomi Hoevenaars; Jens Thing Mortensen; Sieto Bosgra; Anders Malmberg; Merete Ellekilde-Pedersen; Teresa Ramirez-Andersen; Panagiota Diamantopoulou Reiter; Elena Favaro; Ulf Forssmann; Esther C. W. Breij; Maria Jure-Kunkel

Save

From Algorithms to Meaningful Biomarkers: Anchoring AI in Clinical Oncology

Annals of Oncology

IF65.4

2026-01-13

PREAI

E.G.E. de Vries; E. Garralda; S. Litière

Save

MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumors

Future Oncology

IF2.6

2026-01-01

OAAI

Dumbrava, Ecaterina; Minchom, Anna; Henry, Jason; Johnson, Melissa; Sommerhalder, David; Merchan, Jaime; Heist, Rebecca; Cabanas, Elena Garralda; Cotreau, Monette; Goenaga, Anne-Laure; Burzyn, Dalia; Makris, Lukas; Culm, Kerry; Abbadessa, Giovanni

Save

Clinically feasible liver tumour cell size measurement through histology-informed in vivo diffusion MRI

Communications Medicine

IF6.3

2025-11-20

OAAI

Francesco Grussu; Athanasios Grigoriou; Kinga Bernatowicz; Marco Palombo; Irene Casanova-Salas; Daniel Navarro-Garcia; Ignasi Barba; Sara Simonetti; Garazi Serna; Carlos Macarro; Anna Kira Voronova; Valezka Garay; Juan Francisco Corral; Marta Vidorreta; Pablo García-Polo García; Xavier Merino; Richard Mast; Núria Rosón; Manuel Escobar; Maria Vieito; Rodrigo Toledo; Paolo Nuciforo; Joaquin Mateo; Elena Garralda; Raquel Perez-Lopez

Save

Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors

ESMO Open

IF8.3

2025-11-06

OAAI

R. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero

Save

Corrigendum to “Dose optimization in cancer drug development: Review and outcome of a multi-stakeholder workshop”[Eur. J. Cancer 226 (2025), 115593]

European Journal of Cancer

IF7.1

2025-10-10

PREAI

Axel Glasmacher; Elena Garralda; Chad Gwaltney; Katrin Rupalla; Chunze Li; Harald Weber

Save

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

ESMO Open

IF8.3

2025-09-30

OAAI

E. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero

Save

Dose optimization in cancer drug development: Review and outcome of a multi-stakeholder workshop

European Journal of Cancer

IF7.1

2025-06-28

PREAI

Axel Glasmacher; Elena Garralda; Chad Gwaltney; Katrin Rupalla; Chunze Li; Harald Weber

Save

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2025-05-01

OAAI

Qi, Changsong; Shen, Lin; Andre, Thierry; Chung, Hyun Cheol; Cannon, Timothy L.; Garralda, Elena; Italiano, Antoine; Rieke, Damian T.; Liu, Tianshu; Burcoveanu, Domnita-Ileana; Neu, Natascha; Mussi, Chiara E.; Xu, Rui-Hua; Hong, David S.; Drilon, Alexander; Berlin, Jordan

Save

Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis

Annals of Oncology

IF65.4

2025-04-08

PREAI

S. Martín-Lluesma; U. Dafni; K. Vervita; D. Karlis; G. Dimopoulou; Z. Tsourti; G. Villacampa; V. Galvao; J. Lostes; E. Muñoz-Couselo; M. Rotxés; X. Villalobos; S. Muñoz; J.B.A.G. Haanen; I.M. Svane; J.M. Piulats; J. Martin-Liberal; A. Gros; G. Coukos; E. Garralda

Save

A CT-based deep learning-driven tool for automatic liver tumor detection and delineation in patients with cancer

CELL REPORTS MEDICINE

IF10.6

2025-04-01

OAAI

Balaguer-Montero, Maria; Morales, Adria Marcos; Ligero, Marta; Zatse, Christina; Leiva, David; Atlagich, Luz M.; Staikoglou, Nikolaos; Viaplana, Cristina; Monreal, Camilo; Mateo, Joaquin; Hernando, Jorge; Garcia-Alvarez, Alejandro; Salva, Francesc; Capdevila, Jaume; Elez, Elena; Dienstmann, Rodrigo; Garralda, Elena; Perez-Lopez, Raquel

Save

Mapping MAGE-A4 expression in solid cancers for targeted therapies

FRONTIERS IN ONCOLOGY

IF3.3

2025-03-13

OAAI

Habigt, Christin; Rottey, Sylvie; Spanggaard, Iben; Lopez, Juanita S.; Garralda, Elena; Calvo, Emiliano; Bechter, Oliver; Desai, Jayesh; Galot, Rachel; Gandhi, Leena; Heil, Florian; Rieder, Natascha; Dimitrov, Ivan; Quetglas, Iris Martinez; Heichinger, Christian; Keshelava, Nino; Roller, Andreas

Save

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours ( vol 637 , pg 1218 , 2025)

NATURE

IF48.5

2025-02-25

OAAI

Melero, Ignacio; de Miguel Luken, Maria; de Velasco, Guillermo; Garralda, Elena; Martin-Liberal, Juan; Joerger, Markus; Alonso, Guzman; Goebeler, Maria-Elisabeth; Koenig, David; Dummer, Reinhard; Reig, Maria; Rodriguez Ruiz, Maria-Esperanza; Calvo, Emiliano; Esteban-Villarrubia, Jorge; Oberoi, Arjun; Sabat, Paula; Soto-Castillo, Juan Jose; Koster, Kira-Lee; Saavedra, Omar; Sayehli, Cyrus; Gromke, Tanja; Laeubli, Heinz; Ramelyte, Egle; Fortuny, Marta; Landa-Magdalena, Ana; Moreno, Irene; Torres-Jimenez, Javier; Hernando-Calvo, Alberto; Hess, Dagmar; Racca, Fabricio; Richly, Heike; Schmitt, Andreas M.; Eggenschwiler, Corinne; Sanduzzi-Zamparelli, Marco; Vilalta-Lacarra, Anna; Trojan, Joerg; Koch, Christine; Galle, Peter R.; Foerster, Friedrich; Trajanoski, Zlatko; Hackl, Hubert; Gogolla, Falk; Koll, Florestan J.; Wild, Peter; Chun, Felix Kyoung Hwan; Reis, Henning; Lloyd, Peter; Machacek, Matthias; Gajewski, Thomas F.; Fridman, Wolf H.; Eggermont, Alexander M. M.; Bargou, Ralf; Schoeniger, Sandra; Rueschoff, Josef; Tereshchenko, Anastasiia; Zink, Carina; da Silva, Antonio; Lichtenegger, Felix S.; Akdemir, Julia; Ruediger, Manfred; L'Huillier, Phil; Dutta, Aradhana; Haake, Markus; Auckenthaler, Alexandra; Gjorgjioska, Ana; Roessler, Bernhard; Hermann, Frank; Liebig, Mara; Reichhardt, Daniela; Schuberth-Wagner, Christine; Wischhusen, Joerg; Fettes, Petra; Auer, Marlene; Klar, Kathrin; Leo, Eugen

Save

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

ANNALS OF ONCOLOGY

IF65.4

2024-11-01

OAAI

Westphalen, C. B.; Martins-Branco, D.; Beal, J. R.; Cardone, C.; Coleman, N.; Schram, A. M.; Halabi, S.; Michiels, S.; Yap, C.; Andre, F.; Bibeau, F.; Curigliano, G.; Garralda, E.; Kummar, S.; Kurzrock, R.; Limaye, S.; Loges, S.; Marabelle, A.; Marchio, C.; Mateo, J.; Rodon, J.; Spanic, T.; Pentheroudakis, G.; Subbiah, V.

Save

A PRELIMINARY SIGNS OF CLINICAL ACTIVITY OF TUVUSERTIB (M1774), A HIGHLY POTENT ORAL ATR INHIBITOR, IN REFRACTORY IDH MUTATED GLIOMA PATIENTS WITH P53 AND ATRX MUTATIONS; A CASE SERIES FROM A FIH STUDY

NEURO-ONCOLOGY

IF13.4

2024-10-17

PREAI

Vieito, M.; Moreno, I; Gomez-Puerto, D.; Ruiz, I. Victoria; Indacochea, A.; Garralda, E.; Gonzalez, S.; Calvo, E.; Juanita, L.; Szucs, Z.; Reischmann, N.; Pineda, E.

Save

Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Jedrzejewski, J.; Blaszkowska, M.; Dziadziuszko, R.; Alonso, G.; Falkowski, A.; Rzymski, T.; Wilkinson, G.; Kuklik, R.; Nogai, H.; Lugowska, I.; Dawidowska, A.; Boni, V.; Rojas, K.; Pretelli, G.; Garralda, E.

Save

Fadraciclib, an oral CDK2/9 inhibitor, in patients with advanced solid tumors and lymphoma with CDKN2A and/or CDKN2B genetic alterations

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Piha-Paul, S.; Garralda, E.; Vieito, M.; Oh, D. Y.; Huang, J.; Villalona-Calero, M.

Save

TT125-802, a highly selective bromodomain inhibitor of CBP/p300, in patients with advanced solid tumors: an update on the phase I study

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Boni, V.; Antras, J. Fuentes; Garralda, E.; Saavedra, O.; Colombo, I.; Stathis, A.; Homicsko, K.; Brana, I.; Costanzo, S.; Gruber, D.; Cesano, A.; Fluckiger-Mangual, S.

Save

Research Directions